{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:39:47Z","timestamp":1792175987003,"version":"4.4.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG070973"],"award-info":[{"award-number":["R01AG070973"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017675","name":"William F. Vilas Trust Estate","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017675","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03828-w","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:06:13Z","timestamp":1776909973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Type-1 interferons associated with microglial-mediated neuroinflammation in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Daniel C.","family":"Shippy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler K.","family":"Ulland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"3828_CR1","doi-asserted-by":"publisher","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20:3708\u2013821. https:\/\/doi.org\/10.1002\/alz.13809.","DOI":"10.1002\/alz.13809"},{"key":"3828_CR2","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, et al. Donanemab in Early Alzheimer\u2019s Disease. N Engl J Med. 2021;384:1691\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2100708.","journal-title":"N Engl J Med"},{"key":"3828_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","volume":"13","author":"CJ Swanson","year":"2021","unstructured":"Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody. Alzheimers Res Ther. 2021;13:80. https:\/\/doi.org\/10.1186\/s13195-021-00813-8.","journal-title":"Alzheimers Res Ther"},{"key":"3828_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med. 2023;388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"key":"3828_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","volume":"8","author":"A Alzheimer","year":"1995","unstructured":"Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR. An English translation of Alzheimer\u2019s 1907 paper, Uber eine eigenartige Erkankung der Hirnrinde. Clin Anat. 1995;8:429\u201331. https:\/\/doi.org\/10.1002\/ca.980080612.","journal-title":"Clin Anat"},{"key":"3828_CR6","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1:a006189. https:\/\/doi.org\/10.1101\/cshperspect.a006189.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3828_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/WAD.0b013e3182163b62","volume":"26","author":"LG Apostolova","year":"2012","unstructured":"Apostolova LG, Green AE, Babakchanian S, Hwang KS, Chou Y-Y, Toga AW, et al. Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease. Alzheimer Dis Assoc Disord. 2012;26:17\u201327. https:\/\/doi.org\/10.1097\/WAD.0b013e3182163b62.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3828_CR8","doi-asserted-by":"publisher","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman DM, Morris JC, Goate AM. Alzheimer\u2019s disease: the challenge of the second century. Sci Transl Med. 2011;3:77sr1. https:\/\/doi.org\/10.1126\/scitranslmed.3002369.","journal-title":"Sci Transl Med"},{"key":"3828_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-981-32-9358-8_16","volume":"1184","author":"G Gallardo","year":"2019","unstructured":"Gallardo G, Holtzman DM. Amyloid-\u03b2 and Tau at the Crossroads of Alzheimer\u2019s Disease. Adv Exp Med Biol. 2019;1184:187\u2013203. https:\/\/doi.org\/10.1007\/978-981-32-9358-8_16.","journal-title":"Adv Exp Med Biol"},{"key":"3828_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models. Cell. 2010;142:387\u201397. https:\/\/doi.org\/10.1016\/j.cell.2010.06.036.","journal-title":"Cell"},{"key":"3828_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24:29\u201338. https:\/\/doi.org\/10.1038\/nm.4443.","journal-title":"Nat Med"},{"key":"3828_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","volume":"25","author":"MT Heneka","year":"2025","unstructured":"Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, et al. Neuroinflammation in Alzheimer disease. Nat Rev Immunol. 2025;25:321\u201352. https:\/\/doi.org\/10.1038\/s41577-024-01104-7.","journal-title":"Nat Rev Immunol"},{"key":"3828_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14:388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5.","journal-title":"Lancet Neurol"},{"key":"3828_CR14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron. 2016;90:724\u201339. https:\/\/doi.org\/10.1016\/j.neuron.2016.05.003.","journal-title":"Neuron"},{"key":"3828_CR15","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213:667\u201375. https:\/\/doi.org\/10.1084\/jem.20151948.","journal-title":"J Exp Med"},{"key":"3828_CR16","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques. Nat Commun. 2015;6:6176. https:\/\/doi.org\/10.1038\/ncomms7176.","journal-title":"Nat Commun"},{"key":"3828_CR17","doi-asserted-by":"publisher","first-page":"eabg4980","DOI":"10.1126\/sciadv.abg4980","volume":"7","author":"JH Brelstaff","year":"2021","unstructured":"Brelstaff JH, Mason M, Katsinelos T, McEwan WA, Ghetti B, Tolkovsky AM, et al. Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates. Sci Adv. 2021;7:eabg4980. https:\/\/doi.org\/10.1126\/sciadv.abg4980.","journal-title":"Sci Adv"},{"key":"3828_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41593-021-00951-0","volume":"25","author":"P d\u2019Errico","year":"2022","unstructured":"d\u2019Errico P, Ziegler-Waldkirch S, Aires V, Hoffmann P, Mez\u00f6 C, Erny D, et al. Microglia contribute to the propagation of A\u03b2 into unaffected brain tissue. Nat Neurosci. 2022;25:20\u20135. https:\/\/doi.org\/10.1038\/s41593-021-00951-0.","journal-title":"Nat Neurosci"},{"key":"3828_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna J, Philipp S, Albay R, Reyes-Ruiz JM, Baglietto-Vargas D, LaFerla FM, et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2018;13:11. https:\/\/doi.org\/10.1186\/s13024-018-0244-x.","journal-title":"Mol Neurodegener"},{"key":"3828_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136. https:\/\/doi.org\/10.1126\/science.aad8373.","journal-title":"Science"},{"key":"3828_CR21","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/glia.23046","volume":"64","author":"A Sierra","year":"2016","unstructured":"Sierra A, de Castro F, Del R\u00edo-Hortega J, Rafael Iglesias-Rozas J, Garrosa M, Kettenmann H. The Big-Bang for modern glial biology: Translation and comments on P\u00edo del R\u00edo-Hortega 1919 series of papers on microglia. Glia. 2016;64:1801\u201340. https:\/\/doi.org\/10.1002\/glia.23046.","journal-title":"Glia"},{"key":"3828_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052358.","journal-title":"Annu Rev Immunol"},{"key":"3828_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","volume":"53","author":"Y Tang","year":"2016","unstructured":"Tang Y, Le W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol Neurobiol. 2016;53:1181\u201394. https:\/\/doi.org\/10.1007\/s12035-014-9070-5.","journal-title":"Mol Neurobiol"},{"key":"3828_CR24","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41467-022-29552-6","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C, Fan L, Khawaja RR, Liu B, Zhan L, Kodama L, et al. Microglial NF-\u03baB drives tau spreading and toxicity in a mouse model of tauopathy. Nat Commun. 2022;13:1969. https:\/\/doi.org\/10.1038\/s41467-022-29552-6.","journal-title":"Nat Commun"},{"key":"3828_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138. https:\/\/doi.org\/10.1038\/nature11729.","journal-title":"Nature"},{"key":"3828_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1126\/science.149.3681.310","volume":"149","author":"EF Wheelock","year":"1965","unstructured":"Wheelock EF. Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin. Science. 1965;149:310\u20131. https:\/\/doi.org\/10.1126\/science.149.3681.310.","journal-title":"Science"},{"key":"3828_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1098\/rspb.1957.0048","volume":"147","author":"A Isaacs","year":"1957","unstructured":"Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957;147:258\u201367. https:\/\/doi.org\/10.1098\/rspb.1957.0048.","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"3828_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/286110a0","volume":"286","author":"Interferon nomenclature","year":"1980","unstructured":"Interferon nomenclature. Nature. 1980;286:110\u2013110. https:\/\/doi.org\/10.1038\/286110a0.","journal-title":"Nature"},{"key":"3828_CR29","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear HM, Schoggins JW, Diamond MS. Shared and Distinct Functions of Type I and Type III Interferons. Immunity. 2019;50:907\u201323. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.025.","journal-title":"Immunity"},{"key":"3828_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ygeno.2004.03.003","volume":"84","author":"MP Hardy","year":"2004","unstructured":"Hardy MP, Owczarek CM, Jermiin LS, Ejdeb\u00e4ck M, Hertzog PJ. Characterization of the type I interferon locus and identification of novel genes. Genomics. 2004;84:331\u201345. https:\/\/doi.org\/10.1016\/j.ygeno.2004.03.003.","journal-title":"Genomics"},{"key":"3828_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014;14:36\u201349. https:\/\/doi.org\/10.1038\/nri3581.","journal-title":"Nat Rev Immunol"},{"key":"3828_CR32","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.1073\/pnas.87.21.8555","volume":"87","author":"XY Fu","year":"1990","unstructured":"Fu XY, Kessler DS, Veals SA, Levy DE, Darnell JE. ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci U S A. 1990;87:8555\u20139. https:\/\/doi.org\/10.1073\/pnas.87.21.8555.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3828_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6:402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1.","journal-title":"Signal Transduct Target Ther"},{"key":"3828_CR34","doi-asserted-by":"publisher","first-page":"20059","DOI":"10.1074\/jbc.R700016200","volume":"282","author":"C Schindler","year":"2007","unstructured":"Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem. 2007;282:20059\u201363. https:\/\/doi.org\/10.1074\/jbc.R700016200.","journal-title":"J Biol Chem"},{"key":"3828_CR35","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008;455:674\u20138. https:\/\/doi.org\/10.1038\/nature07317.","journal-title":"Nature"},{"key":"3828_CR36","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.1229963","volume":"339","author":"J Wu","year":"2013","unstructured":"Wu J, Sun L, Chen X, Du F, Shi H, Chen C, et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 2013;339:826\u201330. https:\/\/doi.org\/10.1126\/science.1229963.","journal-title":"Science"},{"key":"3828_CR37","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339:786\u201391. https:\/\/doi.org\/10.1126\/science.1232458.","journal-title":"Science"},{"key":"3828_CR38","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2013.04.046","volume":"153","author":"P Gao","year":"2013","unstructured":"Gao P, Ascano M, Wu Y, Barchet W, Gaffney BL, Zillinger T, et al. Cyclic [G(2\u2019,5\u2019)pA(3\u2019,5\u2019)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell. 2013;153:1094\u2013107. https:\/\/doi.org\/10.1016\/j.cell.2013.04.046.","journal-title":"Cell"},{"key":"3828_CR39","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.celrep.2013.05.009","volume":"3","author":"EJ Diner","year":"2013","unstructured":"Diner EJ, Burdette DL, Wilson SC, Monroe KM, Kellenberger CA, Hyodo M, et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep. 2013;3:1355\u201361. https:\/\/doi.org\/10.1016\/j.celrep.2013.05.009.","journal-title":"Cell Rep"},{"key":"3828_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature12306","volume":"498","author":"A Ablasser","year":"2013","unstructured":"Ablasser A, Goldeck M, Cavlar T, Deimling T, Witte G, R\u00f6hl I, et al. cGAS produces a 2\u2019-5\u2019-linked cyclic dinucleotide second messenger that activates STING. Nature. 2013;498:380\u20134. https:\/\/doi.org\/10.1038\/nature12306.","journal-title":"Nature"},{"key":"3828_CR41","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nature08476","volume":"461","author":"H Ishikawa","year":"2009","unstructured":"Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009;461:788\u201392. https:\/\/doi.org\/10.1038\/nature08476.","journal-title":"Nature"},{"key":"3828_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","volume":"51","author":"X Zhang","year":"2013","unstructured":"Zhang X, Shi H, Wu J, Zhang X, Sun L, Chen C, et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell. 2013;51:226\u201335. https:\/\/doi.org\/10.1016\/j.molcel.2013.05.022.","journal-title":"Mol Cell"},{"key":"3828_CR43","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1146\/annurev-immunol-101721-032910","volume":"43","author":"B Zhang","year":"2025","unstructured":"Zhang B, Xu P, Ablasser A. Regulation of the cGAS-STING Pathway. Annu Rev Immunol. 2025;43:667\u201392. https:\/\/doi.org\/10.1146\/annurev-immunol-101721-032910.","journal-title":"Annu Rev Immunol"},{"key":"3828_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12974-025-03563-8","volume":"22","author":"H Li","year":"2025","unstructured":"Li H, Cai R, Zhou Y, Jiang Y, Tan S. cGAS-STING signaling in brain aging and neurodegeneration: molecular links and therapeutic perspectives. J Neuroinflammation. 2025;22:235. https:\/\/doi.org\/10.1186\/s12974-025-03563-8.","journal-title":"J Neuroinflammation"},{"key":"3828_CR45","doi-asserted-by":"publisher","first-page":"106710","DOI":"10.1016\/j.nbd.2024.106710","volume":"202","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zou M, Wu H, Zhu J, Jin T. The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellular and molecular mechanisms in neurodegenerative diseases. Neurobiol Dis. 2024;202:106710. https:\/\/doi.org\/10.1016\/j.nbd.2024.106710.","journal-title":"Neurobiol Dis"},{"key":"3828_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472:481\u20135. https:\/\/doi.org\/10.1038\/nature09907.","journal-title":"Nature"},{"key":"3828_CR47","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1016\/j.apsb.2024.05.012","volume":"14","author":"X Zhou","year":"2024","unstructured":"Zhou X, Wang J, Yu L, Qiao G, Qin D, Yuen-Kwan Law B, et al. Mitophagy and cGAS-STING crosstalk in neuroinflammation. Acta Pharm Sin B. 2024;14:3327\u201361. https:\/\/doi.org\/10.1016\/j.apsb.2024.05.012.","journal-title":"Acta Pharm Sin B"},{"key":"3828_CR48","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2013.09.049","volume":"155","author":"H Konno","year":"2013","unstructured":"Konno H, Konno K, Barber GN. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell. 2013;155:688\u201398. https:\/\/doi.org\/10.1016\/j.cell.2013.09.049.","journal-title":"Cell"},{"key":"3828_CR49","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1016\/j.celrep.2017.11.061","volume":"21","author":"VK Gonugunta","year":"2017","unstructured":"Gonugunta VK, Sakai T, Pokatayev V, Yang K, Wu J, Dobbs N, et al. Trafficking-Mediated STING Degradation Requires Sorting to Acidified Endolysosomes and Can Be Targeted to Enhance Anti-tumor Response. Cell Rep. 2017;21:3234\u201342. https:\/\/doi.org\/10.1016\/j.celrep.2017.11.061.","journal-title":"Cell Rep"},{"key":"3828_CR50","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-021-03762-2","volume":"596","author":"T-T Chu","year":"2021","unstructured":"Chu T-T, Tu X, Yang K, Wu J, Repa JJ, Yan N. Tonic prime-boost of STING signalling mediates Niemann-Pick disease type C. Nature. 2021;596:570\u20135. https:\/\/doi.org\/10.1038\/s41586-021-03762-2.","journal-title":"Nature"},{"key":"3828_CR51","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41467-023-36132-9","volume":"14","author":"M Gentili","year":"2023","unstructured":"Gentili M, Liu B, Papanastasiou M, Dele-Oni D, Schwartz MA, Carlson RJ, et al. ESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling. Nat Commun. 2023;14:611. https:\/\/doi.org\/10.1038\/s41467-023-36132-9.","journal-title":"Nat Commun"},{"key":"3828_CR52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41467-018-02936-3","volume":"9","author":"GJ Seo","year":"2018","unstructured":"Seo GJ, Kim C, Shin W-J, Sklan EH, Eoh H, Jung JU. TRIM56-mediated monoubiquitination of cGAS for cytosolic DNA sensing. Nat Commun. 2018;9:613. https:\/\/doi.org\/10.1038\/s41467-018-02936-3.","journal-title":"Nat Commun"},{"key":"3828_CR53","doi-asserted-by":"publisher","first-page":"eaah7119","DOI":"10.1126\/sciimmunol.aah7119","volume":"2","author":"G Ni","year":"2017","unstructured":"Ni G, Konno H, Barber GN. Ubiquitination of STING at lysine 224 controls IRF3 activation. Sci Immunol. 2017;2:eaah7119. https:\/\/doi.org\/10.1126\/sciimmunol.aah7119.","journal-title":"Sci Immunol"},{"key":"3828_CR54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","volume":"567","author":"X Gui","year":"2019","unstructured":"Gui X, Yang H, Li T, Tan X, Shi P, Li M, et al. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature. 2019;567:262\u20136. https:\/\/doi.org\/10.1038\/s41586-019-1006-9.","journal-title":"Nature"},{"key":"3828_CR55","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41556-023-01098-9","volume":"25","author":"Y Kuchitsu","year":"2023","unstructured":"Kuchitsu Y, Mukai K, Uematsu R, Takaada Y, Shinojima A, Shindo R, et al. STING signalling is terminated through ESCRT-dependent microautophagy of vesicles originating from recycling endosomes. Nat Cell Biol. 2023;25:453\u201366. https:\/\/doi.org\/10.1038\/s41556-023-01098-9.","journal-title":"Nat Cell Biol"},{"key":"3828_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13073-015-0232-5","volume":"7","author":"R Guerreiro","year":"2015","unstructured":"Guerreiro R, Bras J. The age factor in Alzheimer\u2019s disease. Genome Med. 2015;7:106. https:\/\/doi.org\/10.1186\/s13073-015-0232-5.","journal-title":"Genome Med"},{"key":"3828_CR57","doi-asserted-by":"publisher","first-page":"705653","DOI":"10.3389\/fmech.2021.705653","volume":"7","author":"Y Blinkouskaya","year":"2021","unstructured":"Blinkouskaya Y, Weickenmeier J. Brain Shape Changes Associated With Cerebral Atrophy in Healthy Aging and Alzheimer\u2019s Disease. Front Mech Eng. 2021;7:705653. https:\/\/doi.org\/10.3389\/fmech.2021.705653.","journal-title":"Front Mech Eng"},{"key":"3828_CR58","doi-asserted-by":"publisher","first-page":"931536","DOI":"10.3389\/fnagi.2022.931536","volume":"14","author":"J Lee","year":"2022","unstructured":"Lee J, Kim H-J. Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes. Front Aging Neurosci. 2022;14:931536. https:\/\/doi.org\/10.3389\/fnagi.2022.931536.","journal-title":"Front Aging Neurosci"},{"key":"3828_CR59","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fnins.2018.00464","volume":"12","author":"A Moreno-Garc\u00eda","year":"2018","unstructured":"Moreno-Garc\u00eda A, Kun A, Calero O, Medina M, Calero M. An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration. Front Neurosci. 2018;12:464. https:\/\/doi.org\/10.3389\/fnins.2018.00464.","journal-title":"Front Neurosci"},{"key":"3828_CR60","unstructured":"Peters A. The effects of normal aging on nerve fibers and neuroglia in the central nervous system. In: Riddle DR, editor. Brain Aging: Models, Methods, and Mechanisms. Boca Raton (FL): CRC Press\/Taylor & Francis. 2007. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK3873\/.\u00a0Cited 6 Jan\u00a02026\u00a0 . Accessed 6 Jan 2026."},{"key":"3828_CR61","doi-asserted-by":"publisher","first-page":"650038","DOI":"10.3389\/fnagi.2021.650038","volume":"13","author":"B Wang","year":"2021","unstructured":"Wang B, Huang M, Shang D, Yan X, Zhao B, Zhang X. Mitochondrial Behavior in Axon Degeneration and Regeneration. Front Aging Neurosci. 2021;13:650038. https:\/\/doi.org\/10.3389\/fnagi.2021.650038.","journal-title":"Front Aging Neurosci"},{"key":"3828_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuroscience.2012.09.077","volume":"251","author":"DL Dickstein","year":"2013","unstructured":"Dickstein DL, Weaver CM, Luebke JI, Hof PR. Dendritic spine changes associated with normal aging. Neuroscience. 2013;251:21\u201332. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.09.077.","journal-title":"Neuroscience"},{"key":"3828_CR63","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","volume":"27","author":"EG Knox","year":"2022","unstructured":"Knox EG, Aburto MR, Clarke G, Cryan JF, O\u2019Driscoll CM. The blood-brain barrier in aging and neurodegeneration. Mol Psychiatry. 2022;27:2659\u201373. https:\/\/doi.org\/10.1038\/s41380-022-01511-z.","journal-title":"Mol Psychiatry"},{"key":"3828_CR64","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","volume":"8","author":"X Li","year":"2023","unstructured":"Li X, Li C, Zhang W, Wang Y, Qian P, Huang H. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct Target Ther. 2023;8:239. https:\/\/doi.org\/10.1038\/s41392-023-01502-8.","journal-title":"Signal Transduct Target Ther"},{"key":"3828_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.smim.2018.09.003","volume":"40","author":"T Fulop","year":"2018","unstructured":"Fulop T, Witkowski JM, Olivieri F, Larbi A. The integration of inflammaging in age-related diseases. Semin Immunol. 2018;40:17\u201335. https:\/\/doi.org\/10.1016\/j.smim.2018.09.003.","journal-title":"Semin Immunol"},{"key":"3828_CR66","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi C, Bonaf\u00e8 M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244\u201354. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06651.x.","journal-title":"Ann N Y Acad Sci"},{"key":"3828_CR67","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.14336\/AD.2023.1001","volume":"15","author":"L Soraci","year":"2024","unstructured":"Soraci L, Corsonello A, Paparazzo E, Montesanto A, Piacenza F, Olivieri F, et al. Neuroinflammaging: A Tight Line Between Normal Aging and Age-Related Neurodegenerative Disorders. Aging Dis. 2024;15:1726\u201347. https:\/\/doi.org\/10.14336\/AD.2023.1001.","journal-title":"Aging Dis"},{"key":"3828_CR68","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.exger.2018.07.010","volume":"111","author":"K Yao","year":"2018","unstructured":"Yao K, Zhao Y-F. Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice. Exp Gerontol. 2018;111:86\u201393. https:\/\/doi.org\/10.1016\/j.exger.2018.07.010.","journal-title":"Exp Gerontol"},{"key":"3828_CR69","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/glia.20468","volume":"55","author":"A Sierra","year":"2007","unstructured":"Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia. 2007;55:412\u201324. https:\/\/doi.org\/10.1002\/glia.20468.","journal-title":"Glia"},{"key":"3828_CR70","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s43587-023-00479-x","volume":"3","author":"X Li","year":"2023","unstructured":"Li X, Li Y, Jin Y, Zhang Y, Wu J, Xu Z, et al. Transcriptional and epigenetic decoding of the microglial aging process. Nat Aging. 2023;3:1288\u2013311. https:\/\/doi.org\/10.1038\/s43587-023-00479-x.","journal-title":"Nat Aging"},{"key":"3828_CR71","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.psyneuen.2008.02.013","volume":"33","author":"JB Buchanan","year":"2008","unstructured":"Buchanan JB, Sparkman NL, Chen J, Johnson RW. Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice. Psychoneuroendocrinology. 2008;33:755\u201365. https:\/\/doi.org\/10.1016\/j.psyneuen.2008.02.013.","journal-title":"Psychoneuroendocrinology"},{"key":"3828_CR72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1126\/science.1252945","volume":"346","author":"K Baruch","year":"2014","unstructured":"Baruch K, Deczkowska A, David E, Castellano JM, Miller O, Kertser A, et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science. 2014;346:89\u201393. https:\/\/doi.org\/10.1126\/science.1252945.","journal-title":"Science"},{"key":"3828_CR73","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1101\/gr.240093.118","volume":"29","author":"BA Benayoun","year":"2019","unstructured":"Benayoun BA, Pollina EA, Singh PP, Mahmoudi S, Harel I, Casey KM, et al. Remodeling of epigenome and transcriptome landscapes with aging in mice reveals widespread induction of inflammatory responses. Genome Res. 2019;29:697\u2013709. https:\/\/doi.org\/10.1101\/gr.240093.118.","journal-title":"Genome Res"},{"key":"3828_CR74","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1016\/j.celrep.2019.08.043","volume":"28","author":"T Shavlakadze","year":"2019","unstructured":"Shavlakadze T, Morris M, Fang J, Wang SX, Zhu J, Zhou W, et al. Age-Related Gene Expression Signature in Rats Demonstrate Early, Late, and Linear Transcriptional Changes from Multiple Tissues. Cell Rep. 2019;28:3263\u2013e32733. https:\/\/doi.org\/10.1016\/j.celrep.2019.08.043.","journal-title":"Cell Rep"},{"key":"3828_CR75","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13024-024-00736-6","volume":"19","author":"ER Roy","year":"2024","unstructured":"Roy ER, Li S, Saroukhani S, Wang Y, Cao W. Fate-mapping and functional dissection reveal perilous influence of type I interferon signaling in mouse brain aging. Mol Neurodegener. 2024;19:48. https:\/\/doi.org\/10.1186\/s13024-024-00736-6.","journal-title":"Mol Neurodegener"},{"key":"3828_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-015-0203-5","volume":"3","author":"IR Holtman","year":"2015","unstructured":"Holtman IR, Raj DD, Miller JA, Schaafsma W, Yin Z, Brouwer N, et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun. 2015;3:31. https:\/\/doi.org\/10.1186\/s40478-015-0203-5.","journal-title":"Acta Neuropathol Commun"},{"key":"3828_CR77","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nn.4222","volume":"19","author":"K Grabert","year":"2016","unstructured":"Grabert K, Michoel T, Karavolos MH, Clohisey S, Baillie JK, Stevens MP, et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat Neurosci. 2016;19:504\u201316. https:\/\/doi.org\/10.1038\/nn.4222.","journal-title":"Nat Neurosci"},{"key":"3828_CR78","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41467-017-00769-0","volume":"8","author":"A Deczkowska","year":"2017","unstructured":"Deczkowska A, Matcovitch-Natan O, Tsitsou-Kampeli A, Ben-Hamo S, Dvir-Szternfeld R, Spinrad A, et al. Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner. Nat Commun. 2017;8:717. https:\/\/doi.org\/10.1038\/s41467-017-00769-0.","journal-title":"Nat Commun"},{"key":"3828_CR79","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, et al. Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity. 2019;50:253\u2013e2716. https:\/\/doi.org\/10.1016\/j.immuni.2018.11.004.","journal-title":"Immunity"},{"key":"3828_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s43587-022-00335-4","volume":"3","author":"MT Buckley","year":"2023","unstructured":"Buckley MT, Sun ED, George BM, Liu L, Schaum N, Xu L, et al. Cell-type-specific aging clocks to quantify aging and rejuvenation in neurogenic regions of the brain. Nat Aging. 2023;3:121\u201337. https:\/\/doi.org\/10.1038\/s43587-022-00335-4.","journal-title":"Nat Aging"},{"key":"3828_CR81","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.1111\/febs.70126","volume":"292","author":"JP Lopez-Atalaya","year":"2025","unstructured":"Lopez-Atalaya JP, Bhojwani-Cabrera AM. Type I interferon signalling and interferon-responsive microglia in health and disease. FEBS J. 2025;292:5921\u201340. https:\/\/doi.org\/10.1111\/febs.70126.","journal-title":"FEBS J"},{"key":"3828_CR82","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.1523\/JNEUROSCI.0725-17.2017","volume":"37","author":"A McDonough","year":"2017","unstructured":"McDonough A, Lee RV, Noor S, Lee C, Le T, Iorga M, et al. Ischemia\/Reperfusion Induces Interferon-Stimulated Gene Expression in Microglia. J Neurosci. 2017;37:8292\u2013308. https:\/\/doi.org\/10.1523\/JNEUROSCI.0725-17.2017.","journal-title":"J Neurosci"},{"key":"3828_CR83","doi-asserted-by":"publisher","first-page":"10447","DOI":"10.1038\/s41598-021-89777-1","volume":"11","author":"Y He","year":"2021","unstructured":"He Y, Taylor N, Yao X, Bhattacharya A. Mouse primary microglia respond differently to LPS and poly(I:C) in vitro. Sci Rep. 2021;11:10447. https:\/\/doi.org\/10.1038\/s41598-021-89777-1.","journal-title":"Sci Rep"},{"key":"3828_CR84","doi-asserted-by":"publisher","first-page":"578031","DOI":"10.1016\/j.jneuroim.2023.578031","volume":"375","author":"DC Shippy","year":"2023","unstructured":"Shippy DC, Ulland TK. Genome-wide identification of murine interferon genes in microglial-mediated neuroinflammation in Alzheimer\u2019s disease. J Neuroimmunol. 2023;375:578031. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578031.","journal-title":"J Neuroimmunol"},{"key":"3828_CR85","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12974-021-02277-x","volume":"18","author":"B Viengkhou","year":"2021","unstructured":"Viengkhou B, White MY, Cordwell SJ, Campbell IL, Hofer MJ. A novel phosphoproteomic landscape evoked in response to type I interferon in the brain and in glial cells. J Neuroinflammation. 2021;18:237. https:\/\/doi.org\/10.1186\/s12974-021-02277-x.","journal-title":"J Neuroinflammation"},{"key":"3828_CR86","doi-asserted-by":"publisher","first-page":"8295","DOI":"10.1128\/JVI.79.13.8295-8302.2005","volume":"79","author":"J Wang","year":"2005","unstructured":"Wang J, Campbell IL. Innate STAT1-dependent genomic response of neurons to the antiviral cytokine alpha interferon. J Virol. 2005;79:8295\u2013302. https:\/\/doi.org\/10.1128\/JVI.79.13.8295-8302.2005.","journal-title":"J Virol"},{"key":"3828_CR87","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1002\/glia.23460","volume":"66","author":"W Li","year":"2018","unstructured":"Li W, Viengkhou B, Denyer G, West PK, Campbell IL, Hofer MJ. Microglia have a more extensive and divergent response to interferon-\u03b1 compared with astrocytes. Glia. 2018;66:2058\u201378. https:\/\/doi.org\/10.1002\/glia.23460.","journal-title":"Glia"},{"key":"3828_CR88","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12974-022-02441-x","volume":"19","author":"PK West","year":"2022","unstructured":"West PK, McCorkindale AN, Guennewig B, Ashhurst TM, Viengkhou B, Hayashida E, et al. The cytokines interleukin-6 and interferon-\u03b1 induce distinct microglia phenotypes. J Neuroinflammation. 2022;19:96. https:\/\/doi.org\/10.1186\/s12974-022-02441-x.","journal-title":"J Neuroinflammation"},{"key":"3828_CR89","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.neurobiolaging.2014.03.025","volume":"35","author":"DDA Raj","year":"2014","unstructured":"Raj DDA, Jaarsma D, Holtman IR, Olah M, Ferreira FM, Schaafsma W, et al. Priming of microglia in a DNA-repair deficient model of accelerated aging. Neurobiol Aging. 2014;35:2147\u201360. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.025.","journal-title":"Neurobiol Aging"},{"key":"3828_CR90","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.neurobiolaging.2013.10.089","volume":"35","author":"JM Taylor","year":"2014","unstructured":"Taylor JM, Minter MR, Newman AG, Zhang M, Adlard PA, Crack PJ. Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer\u2019s disease. Neurobiol Aging. 2014;35:1012\u201323. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.10.089.","journal-title":"Neurobiol Aging"},{"key":"3828_CR91","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, Wang B, Wan Y-W, Chiu G, Cole A, Yin Z, et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest. 2020;130:1912\u201330. https:\/\/doi.org\/10.1172\/JCI133737.","journal-title":"J Clin Invest"},{"key":"3828_CR92","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13195-024-01644-z","volume":"16","author":"Q Wang","year":"2024","unstructured":"Wang Q, Yuan S, Wang C, Huang D, Zhang M, Zhan Y, et al. Brain derived \u03b2-interferon is a potential player in Alzheimer\u2019s disease pathogenesis and cognitive impairment. Alzheimers Res Ther. 2024;16:271. https:\/\/doi.org\/10.1186\/s13195-024-01644-z.","journal-title":"Alzheimers Res Ther"},{"key":"3828_CR93","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s43587-022-00337-2","volume":"3","author":"X Xie","year":"2023","unstructured":"Xie X, Ma G, Li X, Zhao J, Zhao Z, Zeng J. Activation of innate immune cGAS-STING pathway contributes to Alzheimer\u2019s pathogenesis in 5\u00d7FAD mice. Nat Aging. 2023;3:202\u201312. https:\/\/doi.org\/10.1038\/s43587-022-00337-2.","journal-title":"Nat Aging"},{"key":"3828_CR94","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41593-023-01315-6","volume":"26","author":"JC Udeochu","year":"2023","unstructured":"Udeochu JC, Amin S, Huang Y, Fan L, Torres ERS, Carling GK, et al. Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience. Nat Neurosci. 2023;26:737\u201350. https:\/\/doi.org\/10.1038\/s41593-023-01315-6.","journal-title":"Nat Neurosci"},{"key":"3828_CR95","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-5728(94)90046-9","volume":"50","author":"H Akiyama","year":"1994","unstructured":"Akiyama H, Ikeda K, Katoh M, McGeer EG, McGeer PL. Expression of MRP14, 27E10, interferon-alpha and leukocyte common antigen by reactive microglia in postmortem human brain tissue. J Neuroimmunol. 1994;50:195\u2013201. https:\/\/doi.org\/10.1016\/0165-5728(94)90046-9.","journal-title":"J Neuroimmunol"},{"key":"3828_CR96","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0304-3940(94)90560-6","volume":"181","author":"T Yamada","year":"1994","unstructured":"Yamada T, Horisberger MA, Kawaguchi N, Moroo I, Toyoda T. Immunohistochemistry using antibodies to alpha-interferon and its induced protein, MxA, in Alzheimer\u2019s and Parkinson\u2019s disease brain tissues. Neurosci Lett. 1994;181:61\u20134. https:\/\/doi.org\/10.1016\/0304-3940(94)90560-6.","journal-title":"Neurosci Lett"},{"key":"3828_CR97","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1038\/s41598-020-59917-0","volume":"10","author":"Z Moore","year":"2020","unstructured":"Moore Z, Mobilio F, Walker FR, Taylor JM, Crack PJ. Abrogation of type-I interferon signalling alters the microglial response to A\u03b21\u201342. Sci Rep. 2020;10:3153. https:\/\/doi.org\/10.1038\/s41598-020-59917-0.","journal-title":"Sci Rep"},{"key":"3828_CR98","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-016-0341-4","volume":"4","author":"MR Minter","year":"2016","unstructured":"Minter MR, Moore Z, Zhang M, Brody KM, Jones NC, Shultz SR, et al. Deletion of the type-1 interferon receptor in APPSWE\/PS1\u2206E9 mice preserves cognitive function and alters glial phenotype. Acta Neuropathol Commun. 2016;4:72. https:\/\/doi.org\/10.1186\/s40478-016-0341-4.","journal-title":"Acta Neuropathol Commun"},{"key":"3828_CR99","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.immuni.2022.03.018","volume":"55","author":"ER Roy","year":"2022","unstructured":"Roy ER, Chiu G, Li S, Propson NE, Kanchi R, Wang B, et al. Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid \u03b2 plaques. Immunity. 2022;55:879\u2013e8946. https:\/\/doi.org\/10.1016\/j.immuni.2022.03.018.","journal-title":"Immunity"},{"key":"3828_CR100","doi-asserted-by":"publisher","first-page":"14550","DOI":"10.1073\/pnas.1206923109","volume":"109","author":"J Di Domizio","year":"2012","unstructured":"Di Domizio J, Dorta-Estremera S, Gagea M, Ganguly D, Meller S, Li P, et al. Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity. Proc Natl Acad Sci U S A. 2012;109:14550\u20135. https:\/\/doi.org\/10.1073\/pnas.1206923109.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3828_CR101","doi-asserted-by":"publisher","first-page":"108398","DOI":"10.1016\/j.celrep.2020.108398","volume":"33","author":"JE Rexach","year":"2020","unstructured":"Rexach JE, Polioudakis D, Yin A, Swarup V, Chang TS, Nguyen T, et al. Tau Pathology Drives Dementia Risk-Associated Gene Networks toward Chronic Inflammatory States and Immunosuppression. Cell Rep. 2020;33:108398. https:\/\/doi.org\/10.1016\/j.celrep.2020.108398.","journal-title":"Cell Rep"},{"key":"3828_CR102","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41467-022-30461-x","volume":"13","author":"JX Meng","year":"2022","unstructured":"Meng JX, Zhang Y, Saman D, Haider AM, De S, Sang JC, et al. Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses. Nat Commun. 2022;13:2692. https:\/\/doi.org\/10.1038\/s41467-022-30461-x.","journal-title":"Nat Commun"},{"key":"3828_CR103","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.stem.2022.06.007","volume":"29","author":"M Jin","year":"2022","unstructured":"Jin M, Xu R, Wang L, Alam MM, Ma Z, Zhu S, et al. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer\u2019s disease. Cell Stem Cell. 2022;29:1135\u2013e11538. https:\/\/doi.org\/10.1016\/j.stem.2022.06.007.","journal-title":"Cell Stem Cell"},{"key":"3828_CR104","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1038\/s41467-021-26851-2","volume":"12","author":"M Jin","year":"2021","unstructured":"Jin M, Shiwaku H, Tanaka H, Obita T, Ohuchi S, Yoshioka Y, et al. Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation. Nat Commun. 2021;12:6565. https:\/\/doi.org\/10.1038\/s41467-021-26851-2.","journal-title":"Nat Commun"},{"key":"3828_CR105","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/alz.13493","volume":"20","author":"SAI Sanford","year":"2024","unstructured":"Sanford SAI, Miller LVC, Vaysburd M, Keeling S, Tuck BJ, Clark J, et al. The type-I interferon response potentiates seeded tau aggregation and exacerbates tau pathology. Alzheimers Dement. 2024;20:1013\u201325. https:\/\/doi.org\/10.1002\/alz.13493.","journal-title":"Alzheimers Dement"},{"key":"3828_CR106","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","volume":"566","author":"T Masuda","year":"2019","unstructured":"Masuda T, Sankowski R, Staszewski O, B\u00f6ttcher C, Amann L, Sagar null, et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature. 2019;566:388\u201392. https:\/\/doi.org\/10.1038\/s41586-019-0924-x.","journal-title":"Nature"},{"key":"3828_CR107","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41467-018-02926-5","volume":"9","author":"M Olah","year":"2018","unstructured":"Olah M, Patrick E, Villani A-C, Xu J, White CC, Ryan KJ, et al. A transcriptomic atlas of aged human microglia. Nat Commun. 2018;9:539. https:\/\/doi.org\/10.1038\/s41467-018-02926-5.","journal-title":"Nat Commun"},{"key":"3828_CR108","doi-asserted-by":"publisher","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","volume-title":"An environment-dependent transcriptional network specifies human microglia identity","author":"D Gosselin","year":"2017","unstructured":"Gosselin D, Skola D, Coufal NG, Holtman IR, Schlachetzki JCM, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Volume 356. New York, N: Science; 2017. p. eaal3222. https:\/\/doi.org\/10.1126\/science.aal3222."},{"key":"3828_CR109","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature. 2019;570:332\u20137. https:\/\/doi.org\/10.1038\/s41586-019-1195-2.","journal-title":"Nature"},{"key":"3828_CR110","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah M, Menon V, Habib N, Taga MF, Ma Y, Yung CJ, et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat Commun. 2020;11:6129. https:\/\/doi.org\/10.1038\/s41467-020-19737-2.","journal-title":"Nat Commun"},{"key":"3828_CR111","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat Med. 2020;26:131\u201342. https:\/\/doi.org\/10.1038\/s41591-019-0695-9.","journal-title":"Nat Med"},{"key":"3828_CR112","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12864-022-08417-8","volume":"23","author":"DC Shippy","year":"2022","unstructured":"Shippy DC, Watters JJ, Ulland TK. Transcriptional response of murine microglia in Alzheimer\u2019s disease and inflammation. BMC Genomics. 2022;23:183. https:\/\/doi.org\/10.1186\/s12864-022-08417-8.","journal-title":"BMC Genomics"},{"key":"3828_CR113","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ibneur.2022.06.002","volume":"13","author":"DC Shippy","year":"2022","unstructured":"Shippy DC, Ulland TK. Exploring the zinc-related transcriptional landscape in Alzheimer\u2019s disease. IBRO Neurosci Rep. 2022;13:31\u20137. https:\/\/doi.org\/10.1016\/j.ibneur.2022.06.002.","journal-title":"IBRO Neurosci Rep"},{"key":"3828_CR114","doi-asserted-by":"publisher","first-page":"14800","DOI":"10.1038\/s41598-023-41897-6","volume":"13","author":"DC Shippy","year":"2023","unstructured":"Shippy DC, Ulland TK. Lipid metabolism transcriptomics of murine microglia in Alzheimer\u2019s disease and neuroinflammation. Sci Rep. 2023;13:14800. https:\/\/doi.org\/10.1038\/s41598-023-41897-6.","journal-title":"Sci Rep"},{"key":"3828_CR115","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1038\/s41467-021-23111-1","volume":"12","author":"A Grubman","year":"2021","unstructured":"Grubman A, Choo XY, Chew G, Ouyang JF, Sun G, Croft NP, et al. Transcriptional signature in microglia associated with A\u03b2 plaque phagocytosis. Nat Commun. 2021;12:3015. https:\/\/doi.org\/10.1038\/s41467-021-23111-1.","journal-title":"Nat Commun"},{"key":"3828_CR116","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-025-09662-z","volume":"648","author":"P Ayata","year":"2025","unstructured":"Ayata P, Crowley JM, Challman MF, Sahasrabuddhe V, Gratuze M, Werneburg S, et al. Lymphoid gene expression supports neuroprotective microglia function. Nature. 2025;648:157\u201365. https:\/\/doi.org\/10.1038\/s41586-025-09662-z.","journal-title":"Nature"},{"key":"3828_CR117","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell. 2017;169:1276\u2013e129017. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018.","journal-title":"Cell"},{"key":"3828_CR118","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, et al. The Major Risk Factors for Alzheimer\u2019s Disease: Age, Sex, and Genes Modulate the Microglia Response to A\u03b2 Plaques. Cell Rep. 2019;27:1293\u2013e13066. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.099.","journal-title":"Cell Rep"},{"key":"3828_CR119","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47:566\u2013e5819. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008.","journal-title":"Immunity"},{"key":"3828_CR120","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.cell.2024.02.020","volume":"187","author":"CC Escoubas","year":"2024","unstructured":"Escoubas CC, Dorman LC, Nguyen PT, Lagares-Linares C, Nakajo H, Anderson SR, et al. Type-I-interferon-responsive microglia shape cortical development and behavior. Cell. 2024;187:1936\u201354. https:\/\/doi.org\/10.1016\/j.cell.2024.02.020. .e24.","journal-title":"Cell"},{"key":"3828_CR121","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12974-025-03659-1","volume":"23","author":"L Calcines-Rodr\u00edguez","year":"2025","unstructured":"Calcines-Rodr\u00edguez L, Noyes-Martel N, Becker JL, Nguyen SK, Osabutey MA, Trojanczyk LA, et al. Microglial interferon signaling and A\u03b2 plaque pathology are enhanced in female 5xFAD Alzheimer\u2019s disease mice, independent of estrous cycle stage. J Neuroinflammation. 2025;23:41. https:\/\/doi.org\/10.1186\/s12974-025-03659-1.","journal-title":"J Neuroinflammation"},{"key":"3828_CR122","doi-asserted-by":"publisher","first-page":"104175","DOI":"10.1016\/j.ebiom.2022.104175","volume":"82","author":"L Song","year":"2022","unstructured":"Song L, Chen J, Lo C-YZ, Guo Q, Consortium ZIB, Feng J, et al. Impaired type I interferon signaling activity implicated in the peripheral blood transcriptome of preclinical Alzheimer\u2019s disease. EBioMedicine. 2022;82:104175. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104175.","journal-title":"EBioMedicine"},{"key":"3828_CR123","doi-asserted-by":"publisher","first-page":"16488","DOI":"10.1038\/s41598-022-20889-y","volume":"12","author":"A Jana","year":"2022","unstructured":"Jana A, Wang X, Leasure JW, Magana L, Wang L, Kim Y-M, et al. Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer\u2019s disease. Sci Rep. 2022;12:16488. https:\/\/doi.org\/10.1038\/s41598-022-20889-y.","journal-title":"Sci Rep"},{"key":"3828_CR124","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbi.2015.06.008","volume":"49","author":"SD Mesquita","year":"2015","unstructured":"Mesquita SD, Ferreira AC, Gao F, Coppola G, Geschwind DH, Sousa JC, et al. The choroid plexus transcriptome reveals changes in type I and II interferon responses in a mouse model of Alzheimer\u2019s disease. Brain Behav Immun. 2015;49:280\u201392. https:\/\/doi.org\/10.1016\/j.bbi.2015.06.008.","journal-title":"Brain Behav Immun"},{"key":"3828_CR125","doi-asserted-by":"publisher","first-page":"105272","DOI":"10.1016\/j.nbd.2021.105272","volume":"152","author":"F Xue","year":"2021","unstructured":"Xue F, Tian J, Yu C, Du H, Guo L. Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer\u2019s pathology in 5\u00d7FAD mice. Neurobiol Dis. 2021;152:105272. https:\/\/doi.org\/10.1016\/j.nbd.2021.105272.","journal-title":"Neurobiol Dis"},{"key":"3828_CR126","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54:412\u201336. https:\/\/doi.org\/10.1038\/s41588-022-01024-z.","journal-title":"Nat Genet"},{"key":"3828_CR127","doi-asserted-by":"publisher","first-page":"e1008549","DOI":"10.1371\/journal.pgen.1008549","volume":"16","author":"S Ramdhani","year":"2020","unstructured":"Ramdhani S, Navarro E, Udine E, Efthymiou AG, Schilder BM, Parks M, et al. Tensor decomposition of stimulated monocyte and macrophage gene expression profiles identifies neurodegenerative disease-specific trans-eQTLs. PLoS Genet. 2020;16:e1008549. https:\/\/doi.org\/10.1371\/journal.pgen.1008549.","journal-title":"PLoS Genet"},{"key":"3828_CR128","doi-asserted-by":"publisher","first-page":"559342","DOI":"10.3389\/fimmu.2020.559342","volume":"11","author":"O Korvatska","year":"2020","unstructured":"Korvatska O, Kiianitsa K, Ratushny A, Matsushita M, Beeman N, Chien W-M, et al. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer\u2019s Disease Brain. Front Immunol. 2020;11:559342. https:\/\/doi.org\/10.3389\/fimmu.2020.559342.","journal-title":"Front Immunol"},{"key":"3828_CR129","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41422-022-00759-y","volume":"33","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wang Y, Huang G, Yang M, Zhu Y, Jin C, et al. LilrB3 is a putative cell surface receptor of APOE4. Cell Res. 2023;33:116\u201330. https:\/\/doi.org\/10.1038\/s41422-022-00759-y.","journal-title":"Cell Res"},{"key":"3828_CR130","doi-asserted-by":"publisher","first-page":"eabd7695","DOI":"10.1126\/scitranslmed.abd7695","volume":"13","author":"SJ Barker","year":"2021","unstructured":"Barker SJ, Raju RM, Milman NEP, Wang J, Davila-Velderrain J, Gunter-Rahman F, et al. MEF2 is a key regulator of cognitive potential and confers resilience to neurodegeneration. Sci Transl Med. 2021;13:eabd7695. https:\/\/doi.org\/10.1126\/scitranslmed.abd7695.","journal-title":"Sci Transl Med"},{"key":"3828_CR131","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi Y, Liu C-C, Painter MM, Chen X-F, Verbeeck C, Zheng H, et al. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). J Biol Chem. 2015;290:26043\u201350. https:\/\/doi.org\/10.1074\/jbc.M115.679043.","journal-title":"J Biol Chem"},{"key":"3828_CR132","doi-asserted-by":"publisher","first-page":"26033","DOI":"10.1074\/jbc.M115.677286","volume":"290","author":"CC Bailey","year":"2015","unstructured":"Bailey CC, DeVaux LB, Farzan M. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E. J Biol Chem. 2015;290:26033\u201342. https:\/\/doi.org\/10.1074\/jbc.M115.677286.","journal-title":"J Biol Chem"},{"key":"3828_CR133","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160:1061\u201371. https:\/\/doi.org\/10.1016\/j.cell.2015.01.049.","journal-title":"Cell"},{"key":"3828_CR134","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M. TREM2 Binds to Apolipoproteins, Including APOE and CLU\/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia. Neuron. 2016;91:328\u201340. https:\/\/doi.org\/10.1016\/j.neuron.2016.06.015.","journal-title":"Neuron"},{"key":"3828_CR135","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC-C, Ulrich JD, Sergushichev A, Beatty WL, et al. TREM2 Maintains Microglial Metabolic Fitness in Alzheimer\u2019s Disease. Cell. 2017;170:649\u2013e66313. https:\/\/doi.org\/10.1016\/j.cell.2017.07.023.","journal-title":"Cell"},{"key":"3828_CR136","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","volume":"14","author":"TK Ulland","year":"2018","unstructured":"Ulland TK, Colonna M. TREM2 - a key player in microglial biology and Alzheimer disease. Nat Rev Neurol. 2018;14:667\u201375. https:\/\/doi.org\/10.1038\/s41582-018-0072-1.","journal-title":"Nat Rev Neurol"},{"key":"3828_CR137","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-022-00535-x","volume":"17","author":"A Sudwarts","year":"2022","unstructured":"Sudwarts A, Ramesha S, Gao T, Ponnusamy M, Wang S, Hansen M, et al. BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia. Mol Neurodegener. 2022;17:33. https:\/\/doi.org\/10.1186\/s13024-022-00535-x.","journal-title":"Mol Neurodegener"},{"key":"3828_CR138","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A, et al. Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol. 2018;14:457\u201369. https:\/\/doi.org\/10.1038\/s41582-018-0032-9.","journal-title":"Nat Rev Neurol"},{"key":"3828_CR139","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12974-022-02604-w","volume":"19","author":"I Coales","year":"2022","unstructured":"Coales I, Tsartsalis S, Fancy N, Weinert M, Clode D, Owen D, et al. Alzheimer\u2019s disease-related transcriptional sex differences in myeloid cells. J Neuroinflammation. 2022;19:247. https:\/\/doi.org\/10.1186\/s12974-022-02604-w.","journal-title":"J Neuroinflammation"},{"key":"3828_CR140","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","volume":"1","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Rice CM. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol. 2011;1:519\u201325. https:\/\/doi.org\/10.1016\/j.coviro.2011.10.008.","journal-title":"Curr Opin Virol"},{"key":"3828_CR141","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri3344","volume":"13","author":"MS Diamond","year":"2013","unstructured":"Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol. 2013;13:46\u201357. https:\/\/doi.org\/10.1038\/nri3344.","journal-title":"Nat Rev Immunol"},{"key":"3828_CR142","doi-asserted-by":"publisher","first-page":"e00482","DOI":"10.1016\/j.neurot.2024.e00482","volume":"22","author":"Z Kehs","year":"2025","unstructured":"Kehs Z, Cross AC, Li Y-M. From defense to disease: IFITM3 in immunity and Alzheimer\u2019s disease. Neurotherapeutics. 2025;22:e00482. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00482.","journal-title":"Neurotherapeutics"},{"key":"3828_CR143","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41586-020-2681-2","volume":"586","author":"J-Y Hur","year":"2020","unstructured":"Hur J-Y, Frost GR, Wu X, Crump C, Pan SJ, Wong E, et al. The innate immunity protein IFITM3 modulates \u03b3-secretase in Alzheimer\u2019s disease. Nature. 2020;586:735\u201340. https:\/\/doi.org\/10.1038\/s41586-020-2681-2.","journal-title":"Nature"},{"key":"3828_CR144","doi-asserted-by":"publisher","first-page":"e14543","DOI":"10.1002\/alz.14543","volume":"21","author":"Y Feng","year":"2025","unstructured":"Feng Y, Wang S, Yang D, Zheng W, Xia H, Zhu Q, et al. Inhibition of IFITM3 in cerebrovascular endothelium alleviates Alzheimer\u2019s-related phenotypes. Alzheimers Dement. 2025;21:e14543. https:\/\/doi.org\/10.1002\/alz.14543.","journal-title":"Alzheimers Dement"},{"key":"3828_CR145","doi-asserted-by":"publisher","first-page":"e70403","DOI":"10.1096\/fj.202401584RR","volume":"39","author":"Y Feng","year":"2025","unstructured":"Feng Y, Zhou Q, Hu B, Wang S, Chen L, Cai W, et al. Unveiling the role of KLF9-mediated IFITM3 regulation in amyloidogenesis. FASEB J. 2025;39:e70403. https:\/\/doi.org\/10.1096\/fj.202401584RR.","journal-title":"FASEB J"},{"key":"3828_CR146","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s11064-023-03945-5","volume":"48","author":"Z Wu","year":"2023","unstructured":"Wu Z, Tang W, Ibrahim FEEM, Chen X, Yan H, Tao C, et al. A\u03b2 Induces Neuroinflammation and Microglial M1 Polarization via cGAS-STING-IFITM3 Signaling Pathway in BV-2 Cells. Neurochem Res. 2023;48:2881\u201394. https:\/\/doi.org\/10.1007\/s11064-023-03945-5.","journal-title":"Neurochem Res"},{"key":"3828_CR147","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm.4370","volume":"23","author":"EK Allen","year":"2017","unstructured":"Allen EK, Randolph AG, Bhangale T, Dogra P, Ohlson M, Oshansky CM, et al. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans. Nat Med. 2017;23:975\u201383. https:\/\/doi.org\/10.1038\/nm.4370.","journal-title":"Nat Med"},{"key":"3828_CR148","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijid.2021.02.049","volume":"105","author":"M Li","year":"2021","unstructured":"Li M, Li Y-P, Deng H-L, Wang M-Q, Chen Y, Zhang Y-F, et al. DNA methylation and SNP in IFITM3 are correlated with hand, foot and mouth disease caused by enterovirus 71. Int J Infect Dis. 2021;105:199\u2013208. https:\/\/doi.org\/10.1016\/j.ijid.2021.02.049.","journal-title":"Int J Infect Dis"},{"key":"3828_CR149","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/acn3.51289","volume":"8","author":"Y-S Wang","year":"2021","unstructured":"Wang Y-S, Luo Q-L, Guan Y-G, Fan D-Y, Luan G-M, Jing A. HCMV infection and IFITM3 rs12252 are associated with Rasmussen\u2019s encephalitis disease progression. Ann Clin Transl Neurol. 2021;8:558\u201370. https:\/\/doi.org\/10.1002\/acn3.51289.","journal-title":"Ann Clin Transl Neurol"},{"key":"3828_CR150","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/medicina58010055","volume":"58","author":"S-Y Won","year":"2021","unstructured":"Won S-Y, Kim Y-C, Jeong B-H. No Association between Single Nucleotide Polymorphisms (SNPs) of the Interferon-Induced Transmembrane Protein 3 (IFITM3) Gene and the Susceptibility of Alzheimer\u2019s Disease (AD). Medicina (Kaunas). Kaunas Lith. 2021;58:55. https:\/\/doi.org\/10.3390\/medicina58010055.","journal-title":"Kaunas Lith"},{"key":"3828_CR151","doi-asserted-by":"publisher","unstructured":"Pyun J-M, Park YH, Hodges A, Jang J-W, Bice PJ, Kim S et al. Immunity gene IFITM3 variant: Relation to cognition and Alzheimer\u2019s disease pathology. Alzheimers Dement (Amst). Amsterdam, Netherlands. 2022;14:e12317. https:\/\/doi.org\/10.1002\/dad2.12317.","DOI":"10.1002\/dad2.12317"},{"key":"3828_CR152","first-page":"1498","volume-title":"placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group","author":"Randomised double-blind","year":"1998","unstructured":"Randomised double-blind. placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Volume 352. London, England: Lancet; 1998. pp. 1498\u2013504."},{"key":"3828_CR153","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1212\/wnl.56.12.1628","volume":"56","author":"PRISMS Study Group and the University of British Columbia MS\/MRI Analysis Group","year":"2001","unstructured":"PRISMS Study Group and the University of British Columbia MS\/MRI Analysis Group. PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS. Neurology. 2001;56:1628\u201336. https:\/\/doi.org\/10.1212\/wnl.56.12.1628.","journal-title":"Neurology"},{"key":"3828_CR154","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S1474-4422(14)70068-7","volume":"13","author":"PA Calabresi","year":"2014","unstructured":"Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, et al. Pegylated interferon \u03b2-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study. Lancet Neurol. 2014;13:657\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(14)70068-7.","journal-title":"Lancet Neurol"},{"key":"3828_CR155","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12883-018-1145-x","volume":"18","author":"A Traboulsee","year":"2018","unstructured":"Traboulsee A, Li DKB, Cascione M, Fang J, Dangond F, Miller A. Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing-remitting multiple sclerosis at year 1. BMC Neurol. 2018;18:143. https:\/\/doi.org\/10.1186\/s12883-018-1145-x.","journal-title":"BMC Neurol"},{"key":"3828_CR156","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1742-2094-11-30","volume":"11","author":"LME Grimaldi","year":"2014","unstructured":"Grimaldi LME, Zappal\u00e0 G, Iemolo F, Castellano AE, Ruggieri S, Bruno G, et al. A pilot study on the use of interferon beta-1a in early Alzheimer\u2019s disease subjects. J Neuroinflammation. 2014;11:30. https:\/\/doi.org\/10.1186\/1742-2094-11-30.","journal-title":"J Neuroinflammation"},{"key":"3828_CR157","doi-asserted-by":"publisher","first-page":"109661","DOI":"10.1016\/j.pnpbp.2019.109661","volume":"94","author":"S Chavoshinezhad","year":"2019","unstructured":"Chavoshinezhad S, Mohseni Kouchesfahani H, Ahmadiani A, Dargahi L. Interferon beta ameliorates cognitive dysfunction in a rat model of Alzheimer\u2019s disease: Modulation of hippocampal neurogenesis and apoptosis as underlying mechanism. Prog Neuropsychopharmacol Biol Psychiatry. 2019;94:109661. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109661.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3828_CR158","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.brainresbull.2019.06.015","volume":"150","author":"S Chavoshinezhad","year":"2019","unstructured":"Chavoshinezhad S, Mohseni Kouchesfahani H, Salehi MS, Pandamooz S, Ahmadiani A, Dargahi L. Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of Alzheimer\u2019s disease. Brain Res Bull. 2019;150:297\u2013306. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.06.015.","journal-title":"Brain Res Bull"},{"key":"3828_CR159","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12974-019-1417-4","volume":"16","author":"G Mud\u00f2","year":"2019","unstructured":"Mud\u00f2 G, Frinchi M, Nuzzo D, Scaduto P, Plescia F, Massenti MF, et al. Anti-inflammatory and cognitive effects of interferon-\u03b21a (IFN\u03b21a) in a rat model of Alzheimer\u2019s disease. J Neuroinflammation. 2019;16:44. https:\/\/doi.org\/10.1186\/s12974-019-1417-4.","journal-title":"J Neuroinflammation"},{"key":"3828_CR160","doi-asserted-by":"publisher","first-page":"136968","DOI":"10.1016\/j.neulet.2022.136968","volume":"792","author":"M Farhangian","year":"2023","unstructured":"Farhangian M, Azarafrouz F, Chavoshinezhad S, Dargahi L. Intranasal interferon-beta alleviates anxiety and depressive-like behaviors by modulating microglia polarization in an Alzheimer\u2019s disease model. Neurosci Lett. 2023;792:136968. https:\/\/doi.org\/10.1016\/j.neulet.2022.136968.","journal-title":"Neurosci Lett"},{"key":"3828_CR161","doi-asserted-by":"publisher","first-page":"102262","DOI":"10.1016\/j.npep.2022.102262","volume":"95","author":"F Azarafrouz","year":"2022","unstructured":"Azarafrouz F, Farhangian M, Chavoshinezhad S, Dargahi S, Nassiri-Asl M, Dargahi L. Interferon beta attenuates recognition memory impairment and improves brain glucose uptake in a rat model of Alzheimer\u2019s disease: Involvement of mitochondrial biogenesis and PI3K pathway. Neuropeptides. 2022;95:102262. https:\/\/doi.org\/10.1016\/j.npep.2022.102262.","journal-title":"Neuropeptides"},{"key":"3828_CR162","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2567.2006.02518.x","volume":"121","author":"M Zafranskaya","year":"2007","unstructured":"Zafranskaya M, Oschmann P, Engel R, Weishaupt A, van Noort JM, Jomaa H, et al. Interferon-beta therapy reduces CD4\u2009+\u2009and CD8\u2009+\u2009T-cell reactivity in multiple sclerosis. Immunology. 2007;121:29\u201339. https:\/\/doi.org\/10.1111\/j.1365-2567.2006.02518.x.","journal-title":"Immunology"},{"key":"3828_CR163","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0165-5728(02)00182-0","volume":"129","author":"X Feng","year":"2002","unstructured":"Feng X, Petraglia AL, Chen M, Byskosh PV, Boos MD, Reder AT. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1. J Neuroimmunol. 2002;129:205\u201315. https:\/\/doi.org\/10.1016\/s0165-5728(02)00182-0.","journal-title":"J Neuroimmunol"},{"key":"3828_CR164","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ebiom.2019.09.059","volume":"49","author":"X Feng","year":"2019","unstructured":"Feng X, Bao R, Li L, Deisenhammer F, Arnason BGW, Reder AT. Interferon-\u03b2 corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection. EBioMedicine. 2019;49:269\u201383. https:\/\/doi.org\/10.1016\/j.ebiom.2019.09.059.","journal-title":"EBioMedicine"},{"key":"3828_CR165","doi-asserted-by":"publisher","first-page":"e169562","DOI":"10.1172\/JCI169562","volume":"134","author":"B Viengkhou","year":"2024","unstructured":"Viengkhou B, Hong C, Mazur C, Damle S, Gallo NB, Fang TC, et al. Interferon-\u03b1 receptor antisense oligonucleotides reduce neuroinflammation and neuropathology in a mouse model of cerebral interferonopathy. J Clin Invest. 2024;134:e169562. https:\/\/doi.org\/10.1172\/JCI169562.","journal-title":"J Clin Invest"},{"key":"3828_CR166","doi-asserted-by":"publisher","first-page":"106094","DOI":"10.1016\/j.bbi.2025.106094","volume":"130","author":"T Zhang","year":"2025","unstructured":"Zhang T, Ruan J, Liu Z, Yu Y, Lu Y, Zhang X, et al. Ketone monoester alleviates cognitive impairment in a transgenic mouse model of Alzheimer\u2019s disease through innate immunological IFITM3 pathway. Brain Behav Immun. 2025;130:106094. https:\/\/doi.org\/10.1016\/j.bbi.2025.106094.","journal-title":"Brain Behav Immun"},{"key":"3828_CR167","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jcis.2023.04.139","volume":"645","author":"H Xu","year":"2023","unstructured":"Xu H, Liu Y. ROS-responsive nanomodulators downregulate IFITM3 expression and eliminate ROS for Alzheimer\u2019s disease combination treatment. J Colloid Interface Sci. 2023;645:210\u20138. https:\/\/doi.org\/10.1016\/j.jcis.2023.04.139.","journal-title":"J Colloid Interface Sci"},{"key":"3828_CR168","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/s12276-024-01295-y","volume":"56","author":"S Chung","year":"2024","unstructured":"Chung S, Jeong J-H, Park J-C, Han JW, Lee Y, Kim J-I, et al. Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u2019s disease pathologies. Exp Mol Med. 2024;56:1936\u201351. https:\/\/doi.org\/10.1038\/s12276-024-01295-y.","journal-title":"Exp Mol Med"},{"key":"3828_CR169","doi-asserted-by":"publisher","first-page":"175809","DOI":"10.1016\/j.ejphar.2023.175809","volume":"953","author":"D Gao","year":"2023","unstructured":"Gao D, Hao J-P, Li B-Y, Zheng C-C, Miao B-B, Zhang L, et al. Tetrahydroxy stilbene glycoside ameliorates neuroinflammation for Alzheimer\u2019s disease via cGAS-STING. Eur J Pharmacol. 2023;953:175809. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175809.","journal-title":"Eur J Pharmacol"},{"key":"3828_CR170","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bcp.2017.04.016","volume":"137","author":"S Arifuzzaman","year":"2017","unstructured":"Arifuzzaman S, Das A, Kim SH, Yoon T, Lee YS, Jung KH, et al. Selective inhibition of EZH2 by a small molecule inhibitor regulates microglial gene expression essential for inflammation. Biochem Pharmacol. 2017;137:61\u201380. https:\/\/doi.org\/10.1016\/j.bcp.2017.04.016.","journal-title":"Biochem Pharmacol"},{"key":"3828_CR171","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.intimp.2013.07.013","volume":"17","author":"N Jantaratnotai","year":"2013","unstructured":"Jantaratnotai N, Utaisincharoen P, Sanvarinda P, Thampithak A, Sanvarinda Y. Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia. Int Immunopharmacol. 2013;17:483\u20138. https:\/\/doi.org\/10.1016\/j.intimp.2013.07.013.","journal-title":"Int Immunopharmacol"},{"key":"3828_CR172","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1248\/bpb.b14-00116","volume":"37","author":"H Hara","year":"2014","unstructured":"Hara H, Ikeda R, Ninomiya M, Kamiya T, Koketsu M, Adachi T. Newly synthesized hidabeni chalcone derivatives potently suppress LPS-induced NO production via inhibition of STAT1, but not NF-\u03baB, JNK, and p38, pathways in microglia. Biol Pharm Bull. 2014;37:1042\u20139. https:\/\/doi.org\/10.1248\/bpb.b14-00116.","journal-title":"Biol Pharm Bull"},{"key":"3828_CR173","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13195-016-0207-9","volume":"8","author":"J Cummings","year":"2016","unstructured":"Cummings J, Aisen PS, DuBois B, Fr\u00f6lich L, Jack CR, Jones RW, et al. Drug development in Alzheimer\u2019s disease: the path to 2025. Alzheimers Res Ther. 2016;8:39. https:\/\/doi.org\/10.1186\/s13195-016-0207-9.","journal-title":"Alzheimers Res Ther"},{"key":"3828_CR174","doi-asserted-by":"publisher","first-page":"e90633","DOI":"10.7554\/eLife.90633","volume":"13","author":"A Granzotto","year":"2024","unstructured":"Granzotto A, Vissel B, Sensi SL. Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer\u2019s disease research. Elife. 2024;13:e90633. https:\/\/doi.org\/10.7554\/eLife.90633.","journal-title":"Elife"},{"key":"3828_CR175","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s10787-024-01550-8","volume":"32","author":"S Kaur","year":"2024","unstructured":"Kaur S, Sharma KM, Giridharan A, Dandekar VV. Brain resident microglia in Alzheimer\u2019s disease: foe or friends. Inflammopharmacology. 2024;32:2781\u2013800. https:\/\/doi.org\/10.1007\/s10787-024-01550-8.","journal-title":"Inflammopharmacology"},{"key":"3828_CR176","doi-asserted-by":"publisher","first-page":"e2423973122","DOI":"10.1073\/pnas.2423973122","volume":"122","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Pan W, Chen Y, Zhou D, Ren S, Tong Q, et al. ApoD mediates age-associated increase in vulnerability to influenza virus infection. Proc Natl Acad Sci U S A. 2025;122:e2423973122. https:\/\/doi.org\/10.1073\/pnas.2423973122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3828_CR177","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1038\/s41467-021-22624-z","volume":"12","author":"D Baglietto-Vargas","year":"2021","unstructured":"Baglietto-Vargas D, Forner S, Cai L, Martini AC, Trujillo-Estrada L, Swarup V, et al. Generation of a humanized A\u03b2 expressing mouse demonstrating aspects of Alzheimer\u2019s disease-like pathology. Nat Commun. 2021;12:2421. https:\/\/doi.org\/10.1038\/s41467-021-22624-z.","journal-title":"Nat Commun"},{"key":"3828_CR178","doi-asserted-by":"publisher","unstructured":"Vitek MP, Araujo JA, Fossel M, Greenberg BD, Howell GR, Rizzo SJS et al. Translational animal models for Alzheimer\u2019s disease: An Alzheimer\u2019s Association Business Consortium Think Tank. Alzheimers Dement (N Y). New York, N. Y. 2020;6:e12114. https:\/\/doi.org\/10.1002\/trc2.12114.","DOI":"10.1002\/trc2.12114"},{"key":"3828_CR179","doi-asserted-by":"publisher","first-page":"e072778","DOI":"10.1002\/alz.072778","volume":"19","author":"SJS Rizzo","year":"2023","unstructured":"Rizzo SJS, Haynes KA, Santos DFS, Doolen S, Williams S, Little G, et al. Aging \u00d7 Genetics \u00d7 Environment: Characterization of Precision Disease Models for Preclinical Testing for Late-onset Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2023;19:e072778. https:\/\/doi.org\/10.1002\/alz.072778.","journal-title":"Alzheimer\u2019s Dement"},{"key":"3828_CR180","doi-asserted-by":"publisher","unstructured":"Oblak AL, Forner S, Territo PR, Sasner M, Carter GW, Howell GR et al. Model organism development and evaluation for late-onset Alzheimer\u2019s disease: MODEL-AD. Alzheimers Dement (N Y). New York, N. Y. 2020;6:e12110. https:\/\/doi.org\/10.1002\/trc2.12110.","DOI":"10.1002\/trc2.12110"},{"key":"3828_CR181","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-020-01948-5","volume":"17","author":"DC Shippy","year":"2020","unstructured":"Shippy DC, Wilhelm C, Viharkumar PA, Raife TJ, Ulland TK. \u03b2-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer\u2019s disease pathology. J Neuroinflammation. 2020;17:280. https:\/\/doi.org\/10.1186\/s12974-020-01948-5.","journal-title":"J Neuroinflammation"},{"key":"3828_CR182","doi-asserted-by":"publisher","first-page":"563446","DOI":"10.3389\/fncel.2020.563446","volume":"14","author":"DC Shippy","year":"2020","unstructured":"Shippy DC, Ulland TK. Microglial Immunometabolism in Alzheimer\u2019s Disease. Front Cell Neurosci. 2020;14:563446. https:\/\/doi.org\/10.3389\/fncel.2020.563446.","journal-title":"Front Cell Neurosci"},{"key":"3828_CR183","doi-asserted-by":"publisher","first-page":"15724","DOI":"10.1021\/acsnano.3c03232","volume":"17","author":"F Yang","year":"2023","unstructured":"Yang F, Zhao D, Cheng M, Liu Y, Chen Z, Chang J, et al. mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer\u2019s Disease Management. ACS Nano. 2023;17:15724\u201341. https:\/\/doi.org\/10.1021\/acsnano.3c03232.","journal-title":"ACS Nano"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03828-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03828-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03828-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:23:28Z","timestamp":1780961008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03828-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":183,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3828"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03828-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}